Literature DB >> 2765449

Corneal amyloidosis.

J Watts1, H Frank.   

Abstract

A 54-year-old man presented with a corneal lesion which on excision biopsy was found to be composed of amyloid. This material was presumably laid down in response to chronic irritation from the scarred lid and thus represents an example of secondary localised amyloidosis.

Entities:  

Mesh：

Year:  1989        PMID： 2765449      PMCID： PMC1041844          DOI： 10.1136/bjo.73.8.674

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  7 in total

1.  Amyloidosis of the cornea.

Authors:  R T Collyer
Journal:  Can J Ophthalmol       Date:  1968-01       Impact factor: 1.882

2.  Ophthalmologic aspects of amyloidosis.

Authors:  M H Brownstein; R Elliott; E B Helwig
Journal:  Am J Ophthalmol       Date:  1970-03       Impact factor: 5.258

3.  Localized conjunctival amyloidosis.

Authors:  F C Blodi; D J Apple
Journal:  Am J Ophthalmol       Date:  1979-09       Impact factor: 5.258

4.  Amyloidosis of the cornea. Report of a case without conjunctival involvement.

Authors:  W R Stafford; B S Fine
Journal:  Arch Ophthalmol       Date:  1966-01

5.  Amyloidosis of the conjunctiva--an unusual complication of trachoma: a case report.

Authors:  L C Chumbley; O S Peacock
Journal:  S Afr Med J       Date:  1977-11-19

6.  Immunoglobulin deposition in localized conjunctival amyloidosis.

Authors:  G E Borodic; C K Beyer-Machule; J Millin; J Conte; C S Foster
Journal:  Am J Ophthalmol       Date:  1984-11       Impact factor: 5.258
  7 in total
  2 in total

1.  Localised corneal amyloidosis associated with herpetic keratitis.

Authors:  D Tejwani; A Azuara-Blanco; J MacKenzie
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

2.  Lactoferrin Glu561Asp facilitates secondary amyloidosis in the cornea.

Authors:  K Araki-Sasaki; Y Ando; M Nakamura; K Kitagawa; S Ikemizu; T Kawaji; T Yamashita; M Ueda; K Hirano; M Yamada; K Matsumoto; S Kinoshita; H Tanihara
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.